BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, Rachubinski AL, Wolter-Warmerdam K, Hickey F, Espinosa JM, Blumenthal T. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 2017;7:14818. [PMID: 29093484 DOI: 10.1038/s41598-017-13858-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Veteleanu A, Pape S, Davies K, Kodosaki E, Hye A, Zelek WM, Strydom A, Morgan BP. Complement dysregulation and Alzheimer's disease in Down syndrome. Alzheimers Dement 2022. [PMID: 36149090 DOI: 10.1002/alz.12799] [Reference Citation Analysis]
2 Akoto T, Li JJ, Estes AJ, Karamichos D, Liu Y. The Underlying Relationship between Keratoconus and Down Syndrome. IJMS 2022;23:10796. [DOI: 10.3390/ijms231810796] [Reference Citation Analysis]
3 Panagaki T, Pecze L, Randi EB, Nieminen AI, Szabo C. Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome. Redox Biology 2022;55:102416. [DOI: 10.1016/j.redox.2022.102416] [Reference Citation Analysis]
4 Xu K, Li S, Muskens IS, Elliott N, Myint SS, Pandey P, Hansen HM, Morimoto LM, Kang AY, Ma X, Metayer C, Mueller BA, Roberts I, Walsh KM, Horvath S, Wiemels JL, de Smith AJ. Accelerated epigenetic aging in newborns with Down syndrome. Aging Cell 2022;:e13652. [PMID: 35661546 DOI: 10.1111/acel.13652] [Reference Citation Analysis]
5 Ravaioli F, Zampieri M, Morandi L, Pirazzini C, Pellegrini C, De Fanti S, Gensous N, Pirazzoli GL, Sambati L, Ghezzo A, Ciccarone F, Reale A, Monti D, Salvioli S, Caiafa P, Capri M, Bürkle A, Moreno-villanueva M, Garagnani P, Franceschi C, Bacalini MG. DNA Methylation Analysis of Ribosomal DNA in Adults With Down Syndrome. Front Genet 2022;13:792165. [DOI: 10.3389/fgene.2022.792165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Papendorf JJ, Krüger E, Ebstein F. Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases. Cells 2022;11:1422. [PMID: 35563729 DOI: 10.3390/cells11091422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Martini AC, Gross TJ, Head E, Mapstone M. Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome. Neuron 2022:S0896-6273(22)00309-9. [PMID: 35472307 DOI: 10.1016/j.neuron.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Binstadt BA, Nigrovic PA. The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2022. [PMID: 35413159 DOI: 10.1002/art.42137] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ahmed MM, Wang AC, Elos M, Chial HJ, Sillau S, Solano DA, Coughlan C, Aghili L, Anton P, Markham N, Adame V, Gardiner KJ, Boyd TD, Potter H. The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li F, Zhou Y, Zhang Y, Yin J, Qiu Y, Gao J, Zhu F. POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability. Brief Bioinform 2022:bbac040. [PMID: 35183059 DOI: 10.1093/bib/bbac040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
11 Lambert K, Moo KG, Arnett A, Goel G, Hu A, Flynn KJ, Speake C, Wiedeman AE, Gersuk VH, Linsley PS, Greenbaum CJ, Long SA, Partridge R, Buckner JH, Khor B. Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity. Sci Transl Med 2022;14:eabi4888. [PMID: 35020411 DOI: 10.1126/scitranslmed.abi4888] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Isidor B, Ebstein F, Hurst A, Vincent M, Bader I, Rudy NL, Cogne B, Mayr J, Brehm A, Bupp C, Warren K, Bacino CA, Gerard A, Ranells JD, Metcalfe KA, van Bever Y, Jiang YH, Mendelssohn BA, Cope H, Rosenfeld JA, Blackburn PR, Goodenberger ML, Kearney HM, Kennedy J, Scurr I, Szczaluba K, Ploski R, de Saint Martin A, Alembik Y, Piton A, Bruel AL, Thauvin-Robinet C, Strong A, Diderich KEM, Bourgeois D, Dahan K, Vignard V, Bonneau D, Colin E, Barth M, Camby C, Baujat G, Briceño I, Gómez A, Deb W, Conrad S, Besnard T, Bézieau S, Krüger E, Küry S, Stankiewicz P. Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype. Genet Med 2021:S1098-3600(21)04132-0. [PMID: 34906456 DOI: 10.1016/j.gim.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Danopoulos S, Deutsch GH, Dumortier C, Mariani TJ, Al Alam D. Lung disease manifestations in Down syndrome. Am J Physiol Lung Cell Mol Physiol 2021;321:L892-9. [PMID: 34469245 DOI: 10.1152/ajplung.00434.2020] [Reference Citation Analysis]
14 Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer's disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol 2021;20:930-42. [PMID: 34687637 DOI: 10.1016/S1474-4422(21)00245-3] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
15 Ahmed MM, Johnson NR, Boyd TD, Coughlan C, Chial HJ, Potter H. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners? Front Aging Neurosci 2021;13:718426. [PMID: 34603007 DOI: 10.3389/fnagi.2021.718426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jardine L, Webb S, Goh I, Quiroga Londoño M, Reynolds G, Mather M, Olabi B, Stephenson E, Botting RA, Horsfall D, Engelbert J, Maunder D, Mende N, Murnane C, Dann E, McGrath J, King H, Kucinski I, Queen R, Carey CD, Shrubsole C, Poyner E, Acres M, Jones C, Ness T, Coulthard R, Elliott N, O'Byrne S, Haltalli MLR, Lawrence JE, Lisgo S, Balogh P, Meyer KB, Prigmore E, Ambridge K, Jain MS, Efremova M, Pickard K, Creasey T, Bacardit J, Henderson D, Coxhead J, Filby A, Hussain R, Dixon D, McDonald D, Popescu DM, Kowalczyk MS, Li B, Ashenberg O, Tabaka M, Dionne D, Tickle TL, Slyper M, Rozenblatt-Rosen O, Regev A, Behjati S, Laurenti E, Wilson NK, Roy A, Göttgens B, Roberts I, Teichmann SA, Haniffa M. Blood and immune development in human fetal bone marrow and Down syndrome. Nature 2021;598:327-31. [PMID: 34588693 DOI: 10.1038/s41586-021-03929-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ebstein F, Küry S, Papendorf JJ, Krüger E. Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis. Front Mol Neurosci 2021;14:733012. [PMID: 34566579 DOI: 10.3389/fnmol.2021.733012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Amin RE, Abdel-meguid IE, El-refaie NM, Fakher W, El-tabie D, El-gindy HA. Clinical Profiles, Congenital Heart Disease, and Other Comorbidities Among Egyptian Children with Down Syndrome: A Tertiary Center Study. Journal of Child Science 2021;11:e233-9. [DOI: 10.1055/s-0041-1735537] [Reference Citation Analysis]
19 Do Carmo S, Kannel B, Cuello AC. Nerve Growth Factor Compromise in Down Syndrome. Front Aging Neurosci 2021;13:719507. [PMID: 34434101 DOI: 10.3389/fnagi.2021.719507] [Reference Citation Analysis]
20 Tang J, Fu J, Wang Y, Li B, Li Y, Yang Q, Cui X, Hong J, Li X, Chen Y, Xue W, Zhu F. ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies. Brief Bioinform 2020;21:621-36. [PMID: 30649171 DOI: 10.1093/bib/bby127] [Cited by in Crossref: 52] [Cited by in F6Publishing: 84] [Article Influence: 52.0] [Reference Citation Analysis]
21 Mohamed Khosroshahi L, Parhizkar F, Kachalaki S, Aghebati-Maleki A, Aghebati-Maleki L. Immune checkpoints and reproductive immunology: Pioneers in the future therapy of infertility related Disorders? Int Immunopharmacol 2021;99:107935. [PMID: 34304000 DOI: 10.1016/j.intimp.2021.107935] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Chen XQ, Xing Z, Chen QD, Salvi RJ, Zhang X, Tycko B, Mobley WC, Yu YE. Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome. Front Aging Neurosci 2021;13:700280. [PMID: 34276349 DOI: 10.3389/fnagi.2021.700280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, London J, Mobley W, Strydom A, Okun E. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Front Immunol 2021;12:621440. [PMID: 34248930 DOI: 10.3389/fimmu.2021.621440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Malle L, Bogunovic D. Down syndrome and type I interferon: not so simple. Curr Opin Immunol 2021;72:196-205. [PMID: 34174697 DOI: 10.1016/j.coi.2021.06.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Porras AR, Bramble MS, Mosema Be Amoti K, Spencer D, Dakande C, Manya H, Vashist N, Likuba E, Ebwel JM, Musasa C, Malherbe H, Mohammed B, Tor-Diez C, Ngoyi DM, Katumbay DT, Linguraru MG, Vilain E. Facial analysis technology for the detection of Down syndrome in the Democratic Republic of the Congo. Eur J Med Genet 2021;64:104267. [PMID: 34161860 DOI: 10.1016/j.ejmg.2021.104267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Baker MG, Nowak-Wegrzyn A. Food protein-induced enterocolitis syndrome: epidemiology and comorbidities. Curr Opin Allergy Clin Immunol 2020;20:168-74. [PMID: 31977448 DOI: 10.1097/ACI.0000000000000615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Fernández M, de Coo A, Quintela I, García E, Diniz-Freitas M, Limeres J, Diz P, Blanco J, Carracedo Á, Cruz R. Genetic Susceptibility to Periodontal Disease in Down Syndrome: A Case-Control Study. Int J Mol Sci 2021;22:6274. [PMID: 34200970 DOI: 10.3390/ijms22126274] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Malle L, Bastard P, Martin-Nalda A, Carpenter T, Bush D, Patel R, Colobran R, Soler-Palacin P, Casanova JL, Gans M, Rivière JG, Bogunovic D. Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome. J Clin Immunol 2021. [PMID: 34089457 DOI: 10.1007/s10875-021-01078-4] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
29 Hasaart KAL, Bertrums EJM, Manders F, Goemans BF, van Boxtel R. Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view. Expert Rev Mol Med 2021;23:e5. [PMID: 33902785 DOI: 10.1017/erm.2021.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, Cieuta-Walti C, DeRuisseau LR, Durand S, Esbensen A, Fortea J, Giménez S, Granholm AC, Hahn LJ, Head E, Hillerstrom H, Jacola LM, Janicki MP, Jasien JM, Kamer AR, Kent RD, Khor B, Lawrence JB, Lemonnier C, Lewanda AF, Mobley W, Moore PE, Nelson LP, Oreskovic NM, Osorio RS, Patterson D, Rasmussen SA, Reeves RH, Roizen N, Santoro S, Sherman SL, Talib N, Tapia IE, Walsh KM, Warren SF, White AN, Wong GW, Yi JS. Opportunities, barriers, and recommendations in down syndrome research. Transl Sci Rare Dis 2021;5:99-129. [PMID: 34268067 DOI: 10.3233/trd-200090] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
31 Storchova Z. Consequences of mitotic failure - The penalties and the rewards. Semin Cell Dev Biol 2021;117:149-58. [PMID: 33820699 DOI: 10.1016/j.semcdb.2021.03.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Hart SJ, Worley G, Kishnani PS, Van Mater H. Case Report: Improvement Following Immunotherapy in an Individual With Seronegative Down Syndrome Disintegrative Disorder. Front Neurol 2021;12:621637. [PMID: 33841297 DOI: 10.3389/fneur.2021.621637] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Galbraith MD, Kinning KT, Sullivan KD, Baxter R, Araya P, Jordan KR, Russell S, Smith KP, Granrath RE, Shaw JR, Dzieciatkowska M, Ghosh T, Monte AA, D'Alessandro A, Hansen KC, Benett TD, Hsieh EW, Espinosa JM. Seroconversion stages COVID19 into distinct pathophysiological states. Elife 2021;10:e65508. [PMID: 33724185 DOI: 10.7554/eLife.65508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
34 Flores-Aguilar L, Iulita MF, Kovecses O, Torres MD, Levi SM, Zhang Y, Askenazi M, Wisniewski T, Busciglio J, Cuello AC. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome. Brain 2020;143:3653-71. [PMID: 33206953 DOI: 10.1093/brain/awaa326] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
35 Ferrari M, Stagi S. Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome. Genes (Basel) 2021;12:268. [PMID: 33668420 DOI: 10.3390/genes12020268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Saito MK. Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells. Children (Basel) 2021;8:94. [PMID: 33535645 DOI: 10.3390/children8020094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Marentette JO, Anderson CC, Prutton KM, Jennings EQ, Rauniyar AK, Galligan JJ, Roede JR. Trisomy 21 impairs PGE2 production in dermal fibroblasts. Prostaglandins Other Lipid Mediat 2021;153:106524. [PMID: 33418267 DOI: 10.1016/j.prostaglandins.2020.106524] [Reference Citation Analysis]
38 Buonaguro EF, Bertelli MO. COVID-19 and intellectual disability/autism spectrum disorder with high and very high support needs: issues of physical and mental vulnerability. AMHID 2020;15:8-19. [DOI: 10.1108/amhid-07-2020-0016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Barni S, Giovannini M, Mori F. Epidemiology of non-IgE-mediated food allergies: what can we learn from that? Curr Opin Allergy Clin Immunol 2021;21:188-94. [PMID: 33394702 DOI: 10.1097/ACI.0000000000000721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Tuttle KD, Waugh KA, Araya P, Minter R, Orlicky DJ, Ludwig M, Andrysik Z, Burchill MA, Tamburini BAJ, Sempeck C, Smith K, Granrath R, Tracy D, Baxter J, Espinosa JM, Sullivan KD. JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. Cell Rep 2020;33:108407. [PMID: 33207208 DOI: 10.1016/j.celrep.2020.108407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
41 Vita S, Di Bari V, Corpolongo A, Goletti D, Espinosa J, Petracca S, Palmieri F, Nicastri E; INMI COVID-19 study groups. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome. Int J Infect Dis 2021;103:607-10. [PMID: 33271290 DOI: 10.1016/j.ijid.2020.11.188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
42 Roy ER, Cao W. Antiviral Immune Response in Alzheimer's Disease: Connecting the Dots. Front Neurosci 2020;14:577744. [PMID: 33132831 DOI: 10.3389/fnins.2020.577744] [Reference Citation Analysis]
43 Koenig KA, Bekris LM, Ruedrich S, Weber GE, Khrestian M, Oh SH, Kim S, Wang ZI, Leverenz JB. High-resolution functional connectivity of the default mode network in young adults with down syndrome. Brain Imaging Behav 2021;15:2051-60. [PMID: 33070299 DOI: 10.1007/s11682-020-00399-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Malle L, Gao C, Hur C, Truong HQ, Bouvier NM, Percha B, Kong XF, Bogunovic D. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease. Genet Med 2021;23:576-80. [PMID: 33060835 DOI: 10.1038/s41436-020-01004-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
45 Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, Khanal S, Butcher ET, Estrada BE, Rachubinski AL, McWilliams JA, Minter R, Dimasi T, Colvin KL, Baturin D, Pham AT, Galbraith MD, Bartsch KW, Yeager ME, Porter CC, Sullivan KD, Hsieh EW, Espinosa JM. Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome. Cell Rep 2019;29:1893-1908.e4. [PMID: 31722205 DOI: 10.1016/j.celrep.2019.10.038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
46 Villani ER, Carfì A, Di Paola A, Palmieri L, Donfrancesco C, Lo Noce C, Taruscio D, Meli P, Salerno P, Kodra Y, Pricci F, Tamburo de Bella M, Floridia M, Onder G; The Italian National Institute of Health CoVID‐19 Mortality Group. Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series. Am J Med Genet 2020;182:2964-70. [DOI: 10.1002/ajmg.a.61867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
47 Perepitchka M, Galat Y, Beletsky IP, Iannaccone PM, Galat V. Down syndrome iPSC model: endothelial perspective on tumor development. Oncotarget 2020;11:3387-404. [PMID: 32934781 DOI: 10.18632/oncotarget.27712] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Mortimer GL, Gillespie KM. Early Onset of Autoimmune Diabetes in Children with Down Syndrome-Two Separate Aetiologies or an Immune System Pre-Programmed for Autoimmunity? Curr Diab Rep 2020;20:47. [PMID: 32839884 DOI: 10.1007/s11892-020-01318-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
49 Hasselbalch HC, Skov V, Kjær L, Sørensen TL, Ellervik C, Wienecke T. Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives. J Neuroinflammation 2020;17:248. [PMID: 32829706 DOI: 10.1186/s12974-020-01877-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Gensous N, Bacalini MG, Franceschi C, Garagnani P. Down syndrome, accelerated aging and immunosenescence. Semin Immunopathol 2020;42:635-45. [PMID: 32705346 DOI: 10.1007/s00281-020-00804-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
51 Labrosse R, Graham F, Caubet JC. Non-IgE-Mediated Gastrointestinal Food Allergies in Children: An Update. Nutrients 2020;12:E2086. [PMID: 32674427 DOI: 10.3390/nu12072086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
52 Nicek A, Talib N, Lovell D, Smith C, Becker ML, Jones JT. Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists. Pediatr Rheumatol Online J 2020;18:57. [PMID: 32660497 DOI: 10.1186/s12969-020-00445-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
53 Petersen ME, Zhang F, Schupf N, Krinsky-McHale SJ, Hall J, Mapstone M, Cheema A, Silverman W, Lott I, Rafii MS, Handen B, Klunk W, Head E, Christian B, Foroud T, Lai F, Rosas HD, Zaman S, Ances BM, Wang MC, Tycko B, Lee JH, O'Bryant S; Alzheimer's Biomarker Consortium – Down Syndrome (ABC‐DS). Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study. Alzheimers Dement (Amst) 2020;12:e12039. [PMID: 32626817 DOI: 10.1002/dad2.12039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
54 Laurent AP, Kotecha RS, Malinge S. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome. Leukemia 2020;34:1984-99. [PMID: 32433508 DOI: 10.1038/s41375-020-0854-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
55 Espinosa JM. Down Syndrome and COVID-19: A Perfect Storm? Cell Rep Med 2020;1:100019. [PMID: 32501455 DOI: 10.1016/j.xcrm.2020.100019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 14.0] [Reference Citation Analysis]
56 Yim A, Koti P, Bonnard A, Marchiano F, Dürrbaum M, Garcia-Perez C, Villaveces J, Gamal S, Cardone G, Perocchi F, Storchova Z, Habermann BH. mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations. Nucleic Acids Res 2020;48:605-32. [PMID: 31799603 DOI: 10.1093/nar/gkz1128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
57 Huggard D, Doherty DG, Molloy EJ. Immune Dysregulation in Children With Down Syndrome. Front Pediatr 2020;8:73. [PMID: 32175298 DOI: 10.3389/fped.2020.00073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
58 Bush D, Galambos C, Dunbar Ivy D. Pulmonary hypertension in children with Down syndrome. Pediatr Pulmonol 2021;56:621-9. [PMID: 32049444 DOI: 10.1002/ppul.24687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
59 Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Down syndrome. Nat Rev Dis Primers 2020;6:9. [PMID: 32029743 DOI: 10.1038/s41572-019-0143-7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 125] [Article Influence: 33.0] [Reference Citation Analysis]
60 Weber GE, Koenig KA, Khrestian M, Shao Y, Tuason ED, Gramm M, Lal D, Leverenz JB, Bekris LM. An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report. J Immunol 2020;204:1111-8. [PMID: 31959733 DOI: 10.4049/jimmunol.1901166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
61 Dumortier L, Bricout V. Obstructive sleep apnea syndrome in adults with down syndrome: Causes and consequences. Is it a "chicken and egg" question? Neuroscience & Biobehavioral Reviews 2020;108:124-38. [DOI: 10.1016/j.neubiorev.2019.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
62 Lehallier B, Gate D, Schaum N, Nanasi T, Lee SE, Yousef H, Moran Losada P, Berdnik D, Keller A, Verghese J, Sathyan S, Franceschi C, Milman S, Barzilai N, Wyss-Coray T. Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 2019;25:1843-50. [PMID: 31806903 DOI: 10.1038/s41591-019-0673-2] [Cited by in Crossref: 150] [Cited by in F6Publishing: 185] [Article Influence: 50.0] [Reference Citation Analysis]
63 Araya P, Waugh KA, Sullivan KD, Núñez NG, Roselli E, Smith KP, Granrath RE, Rachubinski AL, Enriquez Estrada B, Butcher ET, Minter R, Tuttle KD, Bruno TC, Maccioni M, Espinosa JM. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A 2019;116:24231-41. [PMID: 31699819 DOI: 10.1073/pnas.1908129116] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
64 Powers RK, Culp-Hill R, Ludwig MP, Smith KP, Waugh KA, Minter R, Tuttle KD, Lewis HC, Rachubinski AL, Granrath RE, Carmona-Iragui M, Wilkerson RB, Kahn DE, Joshi M, Lleó A, Blesa R, Fortea J, D'Alessandro A, Costello JC, Sullivan KD, Espinosa JM. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Nat Commun 2019;10:4766. [PMID: 31628327 DOI: 10.1038/s41467-019-12739-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
65 Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, Canna S, Schulert G, Deterding R, Xu J, Leung AN, Bouzoubaa L, Abulaban K, Baszis K, Behrens EM, Birmingham J, Casey A, Cidon M, Cron RQ, De A, De Benedetti F, Ferguson I, Fishman MP, Goodman SI, Graham TB, Grom AA, Haines K, Hazen M, Henderson LA, Ho A, Ibarra M, Inman CJ, Jerath R, Khawaja K, Kingsbury DJ, Klein-Gitelman M, Lai K, Lapidus S, Lin C, Lin J, Liptzin DR, Milojevic D, Mombourquette J, Onel K, Ozen S, Perez M, Phillippi K, Prahalad S, Radhakrishna S, Reinhardt A, Riskalla M, Rosenwasser N, Roth J, Schneider R, Schonenberg-Meinema D, Shenoi S, Smith JA, Sönmez HE, Stoll ML, Towe C, Vargas SO, Vehe RK, Young LR, Yang J, Desai T, Balise R, Lu Y, Tian L, Bejerano G, Davis MM, Khatri P, Mellins ED; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis 2019;78:1722-31. [PMID: 31562126 DOI: 10.1136/annrheumdis-2019-216040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
66 Caubet J, Cianferoni A, Groetch M, Nowak‐wegrzyn A. Food protein‐induced enterocolitis syndrome. Clin Exp Allergy 2019;49:1178-90. [DOI: 10.1111/cea.13415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
67 Hart SJ, Zimmerman K, Linardic CM, Cannon S, Pastore A, Patsiogiannis V, Rossi P, Santoro SL, Skotko BG, Torres A, Valentini D, Vellody K, Worley G, Kishnani PS. Detection of iron deficiency in children with Down syndrome. Genet Med 2020;22:317-25. [PMID: 31417190 DOI: 10.1038/s41436-019-0637-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Fuchs SY, Staeheli P, Wack A. Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection. Cell Reports 2019;28:245-256.e4. [DOI: 10.1016/j.celrep.2019.05.105] [Cited by in Crossref: 92] [Cited by in F6Publishing: 122] [Article Influence: 30.7] [Reference Citation Analysis]
69 Rachubinski AL, Estrada BE, Norris D, Dunnick CA, Boldrick JC, Espinosa JM. Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata. JAAD Case Rep 2019;5:365-7. [PMID: 31008170 DOI: 10.1016/j.jdcr.2019.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
70 Vacca RA, Bawari S, Valenti D, Tewari D, Nabavi SF, Shirooie S, Sah AN, Volpicella M, Braidy N, Nabavi SM. Down syndrome: Neurobiological alterations and therapeutic targets. Neuroscience & Biobehavioral Reviews 2019;98:234-55. [DOI: 10.1016/j.neubiorev.2019.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
71 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
72 Kulan H, Dag T. In silico identification of critical proteins associated with learning process and immune system for Down syndrome. PLoS One 2019;14:e0210954. [PMID: 30689644 DOI: 10.1371/journal.pone.0210954] [Reference Citation Analysis]
73 Cardinale KM, Bocharnikov A, Hart SJ, Baker JA, Eckstein C, Jasien JM, Gallentine W, Worley G, Kishnani PS, Van Mater H. Immunotherapy in selected patients with Down syndrome disintegrative disorder. Dev Med Child Neurol 2019;61:847-51. [PMID: 30548468 DOI: 10.1111/dmcn.14127] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
74 Chiang JC, Jiang J, Newburger PE, Lawrence JB. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro. Nat Commun 2018;9:5180. [PMID: 30518921 DOI: 10.1038/s41467-018-07630-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
75 Adang LA, Frank DB, Gilani A, Takanohashi A, Ulrick N, Collins A, Cross Z, Galambos C, Helman G, Kanaan U, Keller S, Simon D, Sherbini O, Hanna BD, Vanderver AL. Aicardi goutières syndrome is associated with pulmonary hypertension. Mol Genet Metab 2018;125:351-8. [PMID: 30219631 DOI: 10.1016/j.ymgme.2018.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
76 Norman KC, Moore BB, Arnold KB, O'Dwyer DN. Proteomics: Clinical and research applications in respiratory diseases. Respirology 2018;23:993-1003. [PMID: 30105802 DOI: 10.1111/resp.13383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
77 Fu J, Tang J, Wang Y, Cui X, Yang Q, Hong J, Li X, Li S, Chen Y, Xue W, Zhu F. Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification. Front Pharmacol 2018;9:681. [PMID: 29997509 DOI: 10.3389/fphar.2018.00681] [Cited by in Crossref: 44] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
78 Aziz NM, Guedj F, Pennings JLA, Olmos-Serrano JL, Siegel A, Haydar TF, Bianchi DW. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome. Dis Model Mech 2018;11:dmm031013. [PMID: 29716957 DOI: 10.1242/dmm.031013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
79 [DOI: 10.1101/2020.04.07.024455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 [DOI: 10.1101/315317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]